2015 Annual Survey – Global Pricing in Life Sciences
By Model N and High Point Solutions
“The $US300 billion pharmaceuticals industry is undergoing a profound transformation. Cost containment initiatives by payers, governments and healthcare insurance organizations have created a challenging business environment with controlled pricing, promotion of generic alternatives and greater obstacles to bringing innovative drugs to market. With changing dynamics in the industry, achieving global pricing excellence is now more important than ever in order to continue having a viable industry, yet providing patients affordable access to medicines.
Model N and HighPoint Solutions conducted an annual Global Pricing and Market Access survey of experts in the pharmaceutical industry about the current global pricing business process, internal and external challenges and quality of existing software tools. We collected responses from 59 executives from 30 companies across 13 countries. The objective of the survey was to identify the key trends in the industry and perceived success factors across the globe.
We hope that the insights from the survey contribute to meaningful conversations within your organizations, particularly within the Global, Regional and Country Pricing, Market Access and Finance functions.”
Global Pricing and Market Access, Model N
Director Pricing and Contracting, Highpoint Solutions
Model N and High Point Solutions are Bronze Sponsors at the largest gathering of pharma and payers- Pharma Pricing and Market Access Congress. Join us in February 2016 in London as we celebrate our 10th annual successful congress!